HQY vs GMED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HQY

30.6
AI Score
VS
GMED Wins

GMED

36.8
AI Score

Investment Advisor Scores

HQY

31score
Recommendation
AVOID NEW MONEY

GMED

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HQY GMED Winner
Forward P/E 19.7239 13.8696 GMED
PEG Ratio 1.3157 1.7253 HQY
Revenue Growth 7.6% 5.9% HQY
Earnings Growth 14.7% -26.2% HQY
Tradestie Score 30.6/100 36.8/100 GMED
Profit Margin 17.4% 17.0% HQY
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

HQY 1M: +11.5% · 3M: +6.5% GMED 1M: +10.2% · 3M: +6.6%

Current Technical Phase

HQY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.4 · Price: $100.82

GMED

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.8 · Price: $81.54

Fundamentals Snapshot

Metric HQY GMED
Market Cap — —
Forward P/E 22.2 15.2
Trailing P/E 35.3 20.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 0.7%
Operating Margin 0.3% 0.2%
EPS 2.77 3.90
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.